Planned changes to Medicare
In 2027 the Part D Premium Stabilization Demonstration will end earlier than originally planned. As a result, it is anticipated that some standalone drug plans will raise premium prices, however, the $35 monthly cap on insulin remains in place.
In addition to potential increases in premiums for 2027 the ending of the Premium Stabilization Demonstration also relaxes marketing restrictions on Medicare Advantage plans. It is anticipated that payments to Medicare Advantage plans will increase about 2.48%.
How does this impact people on Medicare? You can expect that if you are in a standalone prescription plan, you’ll see increases in your premiums and potentially on some of the drugs you are currently taking. It may signal to you that a switch to a Medicare Advantage plan is a better choice for you. But proceed with caution. With less protection against particular marketing strategies, you are at greater risk from unscrupulous marketers.
What should you do to protect yourself and ensure you’ve made the best Medicare choice for you. Stay informed about changes to Medicare. Get your information from a reliable, trusted source of information. Get your information from someone who has no vested interest in which plan or type of Medicare policy you select. Get your information from someone certified to provide accurate impartial information, at no cost to you.
Call CHOICES to speak to a counselor about Medicare. 1-800 994-9422.